Enhancing precision medicine for patients with breast cancer brain metastases through functional drug testing
Ellen Wold, Nathan M. Merrill, Habib A. Serhan…·Aki Morikawa
This study uses patient-derived organoids to test drug responses in breast cancer brain metastases, showing subtype-specific variations and the potential of PI3K inhibitors regardless of PIK3CA mutation status.